Eli Lilly acquires cancer program from Scorpion Therapeutics

Scorpion Therapeutics Inc. is selling its lead drug in testing for breast cancer and other advanced solid tumors, to Eli ...
Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan ...
Barclays says reports of Eli Lilly (LLY) reportedly being in talks to acquire Scorpion Therapeutics has a positive read-through to Relay ...
The mergers and acquisitions market has already seen a flurry of deals at the start of 2025 across sectors. Here's a look at ...